The case for screening for vasa previa: time to implement a life‐saving strategy
Ultrasound in Obstetrics & Gynecology · 2023
DOI: 10.1002/uog.26085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2023. Verfasst von Y Oyelese und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, M…. Hauptthemen laut MEDLINE: Vasa Previa. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, UK.
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
- EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.
ORCID-Profile: Y Oyelese, E Jauniaux
Zitieren
APA
Oyelese, Y., Lees, C. C., & Jauniaux, E. (2023). The case for screening for vasa previa: time to implement a life‐saving strategy. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.26085
Vancouver
Oyelese Y, Lees CC, Jauniaux E. The case for screening for vasa previa: time to implement a life‐saving strategy. Ultrasound in Obstetrics & Gynecology. 2023. doi:10.1002/uog.26085
BibTeX
@article{Oyelese2023,
author = {Oyelese, Y and Lees, C C and Jauniaux, E},
title = {The case for screening for vasa previa: time to implement a life‐saving strategy},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2023},
doi = {10.1002/uog.26085}
}
EUVIMED